Description
Marzev 12.5 mg is an oral tablet that contains Omarigliptin, a long-acting Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It is primarily used in the management of type 2 diabetes mellitus. By inhibiting the DPP-4 enzyme, Omarigliptin enhances the effects of incretin hormones, which help regulate blood sugar by increasing insulin secretion and decreasing glucagon levels, thereby lowering blood glucose levels.
This medication is typically prescribed to adults either as monotherapy or in combination with other antidiabetic medications. Marzev is taken once weekly to help control blood sugar levels. It is especially helpful for patients who have difficulty maintaining stable glucose levels with other treatments.
Marzev is not recommended for patients with type 1 diabetes or those with severe kidney impairment without appropriate adjustments. As with all medications, it should be used under the supervision of a healthcare provider to ensure its safety and effectiveness.
 kg 24 pcs.jpg)
 24 PCS.jpg)
.jpg)
.jpg)
 05 Pcs.jpg)
32 pcs.jpg)
.jpg)
 300ml.jpeg)
4 pcs.webp)
 50 Pcs.jpg)
 04 Pcs.jpg)
.jpg)
.webp)
.png)
.jpg)
 BELT 36PCS.jpg)
 48 Pcs.jpg)
.jpeg)
 60Pcs.webp)
32 pcs.jpeg)
4 pcs.jpg)
.webp)
 04 Pcs.png)
 50ML..webp)
 05 Pcs.jpg)
.jpeg)
.webp)
.jpg)
Change Language